
Medicare obesity drug coverage starts July 1, but seniors may miss it
Starting July 1, Medicare coverage for obesity drugs becomes more accessible, yet awareness efforts appear limited.

Pulling the latest in this topic…
C-suite moves, stocks, investments, M&A
1458 briefings briefings in Business

Starting July 1, Medicare coverage for obesity drugs becomes more accessible, yet awareness efforts appear limited.

Her 4-hour daily job-search plan swaps brute-force submitting for alerts, LinkedIn comments, and networking time blocks.

A tiny wording dispute ignited a bigger fight over what markets are actually supposed to measure, and why regulators care.

Herman Hulst confirms layoffs affecting most Destiny and some Marathon teams after Bungie admits Destiny fell short.

The chip giant filed for a Nasdaq listing plan that could raise $29.4 billion, instantly reshaping investor expectations.

Fiscal Q3 results crush estimates, prove AI memory is rewriting Micron's margins, and change the momentum math for the whole chip stack.

The satellite and rocket company’s quick $25 billion borrowing move signals how it plans to finance scale after going public.

On Thursday, Accenture hit its biggest one-day drop on record after forecasting worries that AI could hollow out consulting.

CNBC says SpaceX’s shares surge following its IPO Friday, forcing investors to reprice what “space” and “AI” are worth.

Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.

SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.

The valuation jump of $1T in a single day changes the reference point for risk capital and public-market comps.